Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (63)
  • Anxiety (25)
  • Bipolar Disorder (15)
  • Depression (214)
    • Cardiovascular Disease and Depression (4)
    • Drugs (190)
      • Atypical Antipsychotics (55)
      • Benzodiazepines (40)
      • Bupropion (44)
      • MAOIs (14)
      • SNRIs (82)
      • SSRIs (94)
      • TCAs (38)
      • Typical Antipsychotics (4)
    • Natural Medicines/Supplements (12)
    • Pediatrics (15)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (8)
    • Seasonal Affective Disorder (7)
    • Treatment-Resistant Depression (17)
  • Mental Health (22)
  • Resources (127)
  • Schizophrenia (55)
  • Sleep Disorders (84)
  • Substance Use Disorder (221)
166 - 180 of 190 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: computer alerts about "serotonin syndrome" when entering some drug combos October 2009
Commentary: Nuvigil (Armodafinil) July 2009
Chart: Follow-on Drugs: Therapeutic Benefit or Economic Burden? July 2009
Article: Nuvigil launch brings up more questions about whether new forms of existing drugs are better than the original July 2009
Article: new "opioid" pain medicine called Nucynta (new-SINN-tah, tapentadol) July 2009
Article: The new Aplenzin (uh-PLEN-zin) will add confusion about which bupropion product to choose from the pharmacy shelf May 2009
Commentary: New Drug: Savella (Milnacipran) March 2009
Guideline: Management of fibromyalgia syndrome in adults (2009) March 2009
Article: ads promoting Savella (milnacipran) as the first drug approved ONLY for fibromyalgia March 2009
Article: how Pristiq compares to venlafaxine (Effexor XR, etc) February 2009
Commentary: New Venlafaxine Extended-Release Formulation January 2009
Other: New Venlafaxine Extended-Release Formulation January 2009
Article: A new once-a-day extended-release venlafaxine TABLET will now compete with Effexor XR CAPSULES January 2009
Article: confusion with generic substitution, especially for drugs with multiple brand names December 2008
Article: Running out of medication or refills December 2008
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved